PubMed · 1990 · 75 citations · 0 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyInflammationAnti-inflammatory PharmacologyAsthma PharmacotherapyEicosanoid BiosynthesisInflammation PharmacologyInflammatory Disease PharmacotherapyInflammatory SignalingArachidonic Acid BiosynthesisArachidonic Acid MetabolitesLeukotriene BiosynthesisLeukotriene PathwaysMediatorsProstaglandin Biosynthesis InhibitorsProstaglandin PharmacologyProstaglandin Production
The history of the use of aspirin and salicylate is briefly reviewed, as are the many putative mediators of inflammation. The theory that aspirin-like drugs bring about their anti-inflammatory effects through inhibition of prostaglandin biosynthesis is presented, in the light of other arachidonic acid products such as the leukotrienes. The selective inhibition of cyclo-oxygenase by the large group of aspirin-like non-steroidal anti-inflammatory drugs explains their therapeutic activity. The elucidation of other pathways of oxidative metabolism of arachidonic acid has revealed new targets for the development of drugs with potentially greater therapeutic activity in the treatment of inflammation, cardio-thrombotic diseases and asthma.